Albert Einstein Cancer Center

Bronx, New York 10461

We've found

1 trials

at this facility

Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Status: Enrolling, Phase II
Updated: 7/30/2009

from

Bronx, NY

Use our guide to learn which trials are right for you!